8-K/A

AMENDMENT TO FORM 8-K

Company: Tonix Pharmaceuticals Holding Corp.
Filed: December 27, 2012
Period of Report: December 21, 2012
Accession Number: 0001144204-12-069749

View Document ↗ View on SEC.gov ↗